Q4 2023 · 13F-HR
BRAIDWELL LPholdings as filed
Filed 2024-02-14 · accession 0001420506-24-000478
$2.72B
Reported value
72
Positions
2023-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 40131MAB5 | GH 0 11/15/27 | GUARDANT HEALTH INC | $189.1M | 6.95% | 268,252,000 | Common | SOLE |
| 10806XAB8 | BBIO 2.5 03/15/27 | BRIDGEBIO PHARMA INC | $138.4M | 5.08% | 114,338,000 | Common | SOLE |
| 04351PAD3 | ASND 2.25 04/01/28 | ASCENDIS PHARMA A/S | $130.4M | 4.79% | 126,897,000 | Common | SOLE |
| 30063PAC9 | EXAS 0.375 03/01/28 | EXACT SCIENCES CORP | $123.1M | 4.52% | 131,000,000 | Common | SOLE |
| 67011XAB9 | NVCR 0 11/01/25 | NOVOCURE LTD | $117.9M | 4.33% | 135,834,000 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $94.2M | 3.46% | 715,209 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $81.0M | 2.98% | 1,289,965 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $75.9M | 2.79% | 1,647,311 | Common | SOLE |
| 670704AJ4 | GMED 0.375 03/15/25 | NUVASIVE INC | $74.3M | 2.73% | 80,530,000 | Common | SOLE |
| 45784PAK7 | PODD 0.375 09/01/26 | INSULET CORP | $72.7M | 2.67% | 63,000,000 | Common | SOLE |
| 875372AB0 | TNDM 1.5 05/01/25 | TANDEM DIABETES CARE INC | $67.2M | 2.47% | 71,051,000 | Common | SOLE |
| 23954D109 | DAWNGBX | DAY ONE BIOPHARMACEUTICALS I | $61.5M | 2.26% | 4,215,573 | Common | SOLE |
| 450056106 | IRTC | IRHYTHM TECHNOLOGIES INC | $60.8M | 2.23% | 568,157 | Common | SOLE |
| 04016X101 | ARGX | ARGENX SE | $58.3M | 2.14% | 153,204 | Common | SOLE |
| 10806XAD4 | BBIO 2.25 02/01/29 | BRIDGEBIO PHARMA INC | $57.3M | 2.11% | 67,294,000 | Common | SOLE |
| 457669AA7 | — | INSMED INC | $56.1M | 2.06% | 52,388,000 | Common | SOLE |
| 70975L107 | PEN | PENUMBRA INC | $56.0M | 2.06% | 222,792 | Common | SOLE |
| 803607AD2 | SRPT 1.25 09/15/27 | SAREPTA THERAPEUTICS INC | $51.5M | 1.89% | 50,666,000 | Common | SOLE |
| 64049MAB6 | NEO 0.25 01/15/28 | NEOGENOMICS INC | $50.2M | 1.84% | 65,601,000 | Common | SOLE |
| 761299AB2 | TVTX 2.5 09/15/25 | TRAVERE THERAPEUTICS INC | $47.7M | 1.75% | 56,031,000 | Common | SOLE |
| 252131AK3 | DXCM 0.25 11/15/25 | DEXCOM INC | $47.2M | 1.73% | 45,000,000 | Common | SOLE |
| 492327101 | KROS | KEROS THERAPEUTICS INC | $44.5M | 1.63% | 1,118,961 | Common | SOLE |
| 69913P105 | FNAUSD | PARAGON 28 INC | $41.8M | 1.53% | 3,361,824 | Common | SOLE |
| 45258D105 | IMCR | IMMUNOCORE HLDGS PLC | $41.8M | 1.53% | 611,365 | Common | SOLE |
| 883556102 | TMO | THERMO FISHER SCIENTIFIC INC | $40.2M | 1.48% | 75,749 | Common | SOLE |
| 016255101 | ALGN | ALIGN TECHNOLOGY INC | $40.1M | 1.47% | 146,313 | Common | SOLE |
| 46333XAF5 | — | IRONWOOD PHARMACEUTICALS INC | $39.5M | 1.45% | 37,509,000 | Common | SOLE |
| 64157F103 | NVROEUR | NEVRO CORP | $38.2M | 1.40% | 1,776,368 | Common | SOLE |
| 457730109 | INSP | INSPIRE MED SYS INC | $37.6M | 1.38% | 184,658 | Common | SOLE |
| 68752L100 | KIDS | ORTHOPEDIATRICS CORP | $36.0M | 1.32% | 1,107,770 | Common | SOLE |
| 09058V103 | BCRX | BIOCRYST PHARMACEUTICALS INC | $34.3M | 1.26% | 5,718,477 | Common | SOLE |
| 52490G102 | LEGN | LEGEND BIOTECH CORP | $33.9M | 1.24% | 562,600 | Common | SOLE |
| 56600D107 | MRVI | MARAVAI LIFESCIENCES HLDGS I | $33.0M | 1.21% | 5,040,635 | Common | SOLE |
| 48576UAA4 | — | KARYOPHARM THERAPEUTICS INC | $33.0M | 1.21% | 65,976,000 | Common | SOLE |
| 516544103 | LNTH | LANTHEUS HLDGS INC | $30.7M | 1.13% | 495,100 | Common | SOLE |
| 02081GAB8 | ATEC 0.75 08/01/26 | ALPHATEC HLDGS INC | $28.4M | 1.04% | 26,750,000 | Common | SOLE |
| 014442107 | ALEC | ALECTOR INC | $26.5M | 0.97% | 3,324,308 | Common | SOLE |
| 501147102 | KRYS | KRYSTAL BIOTECH INC | $24.3M | 0.89% | 196,200 | Common | SOLE |
| 89157D105 | TRML | TOURMALINE BIO INC | $23.7M | 0.87% | 906,820 | Common | SOLE |
| 40131M109 | GH | GUARDANT HEALTH INC | $20.5M | 0.75% | 758,928 | Common | SOLE |
| 377322102 | GKOS | GLAUKOS CORP | $19.3M | 0.71% | 242,760 | Common | SOLE |
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $19.0M | 0.70% | 681,101 | Common | SOLE |
| 24344T101 | DCPHEUR | DECIPHERA PHARMACEUTICALS IN | $18.9M | 0.69% | 1,169,490 | Common | SOLE |
| 759916109 | RGEN | REPLIGEN CORP | $18.5M | 0.68% | 102,698 | Common | SOLE |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $17.4M | 0.64% | 2,023,900 | Common | SOLE |
| 46333XAH1 | IRWD 1.5 06/15/26 | IRONWOOD PHARMACEUTICALS INC | $16.9M | 0.62% | 15,500,000 | Common | SOLE |
| 415858109 | HROW | HARROW INC | $16.8M | 0.62% | 1,498,584 | Common | SOLE |
| 031162100 | AMGN | AMGEN INC | $16.8M | 0.62% | 58,200 | Common | SOLE |
| 880881107 | 430 | TERNS PHARMACEUTICALS INC | $15.0M | 0.55% | 2,318,050 | Common | SOLE |
| 46185LAB9 | — | INVITAE CORP | $14.9M | 0.55% | 16,781,000 | Common | SOLE |
| 88427A107 | — | THIRD HARMONIC BIO INC | $14.4M | 0.53% | 1,316,018 | Common | SOLE |
| 690145107 | OMGBP | OUTSET MED INC | $13.0M | 0.48% | 2,400,427 | Common | SOLE |
| 230031106 | CGEM | CULLINAN ONCOLOGY INC | $12.6M | 0.46% | 1,240,865 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $11.4M | 0.42% | 280,158 | Common | SOLE |
| 89422GAA5 | TVTX 2.25 03/01/29 | TRAVERE THERAPEUTICS INC | $11.1M | 0.41% | 16,850,000 | Common | SOLE |
| 00773J202 | SYRE | SPYRE THERAPEUTICS INC | $11.1M | 0.41% | 515,000 | Common | SOLE |
| N5749R100 | 2GH | MERUS N V | $10.2M | 0.37% | 370,679 | Common | SOLE |
| 26818M108 | DYN | DYNE THERAPEUTICS INC | $10.1M | 0.37% | 755,811 | Common | SOLE |
| 745848101 | LUNG | PULMONX CORP | $10.0M | 0.37% | 787,954 | Common | SOLE |
| 24823R105 | DNLI | DENALI THERAPEUTICS INC | $9.9M | 0.36% | 461,769 | Common | SOLE |
| 75382E109 | — | RAPT THERAPEUTICS INC | $9.7M | 0.36% | 389,300 | Common | SOLE |
| 64049MAA8 | — | NEOGENOMICS INC | $9.4M | 0.34% | 10,000,000 | Common | SOLE |
| 89377M109 | TMDX | TRANSMEDICS GROUP INC | $9.3M | 0.34% | 117,701 | Common | SOLE |
| 232109AD0 | — | CUTERA INC | $8.4M | 0.31% | 31,900,000 | Common | SOLE |
| 23306J101 | — | DBV TECHNOLOGIES S A | $7.5M | 0.27% | 7,843,285 | Common | SOLE |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $7.0M | 0.26% | 323,102 | Common | SOLE |
| 00650F109 | ADPT | ADAPTIVE BIOTECHNOLOGIES COR | $6.7M | 0.24% | 1,357,490 | Common | SOLE |
| 232109AG3 | — | CUTERA INC | $6.5M | 0.24% | 29,000,000 | Common | SOLE |
| 462222AD2 | IONS 0 04/01/26 | IONIS PHARMACEUTICALS INC | $5.5M | 0.20% | 5,240,000 | Common | SOLE |
| 43157M102 | — | HILLEVAX INC | $3.3M | 0.12% | 203,407 | Common | SOLE |
| 63009RAD1 | — | NANOSTRING TECHNOLOGIES INC | $2.7M | 0.10% | 3,650,000 | Common | SOLE |
| 20454B104 | CMPX | COMPASS THERAPEUTICS INC | $495,707 | 0.02% | 317,761 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.